FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593152466> ?p ?o ?g. }

• W2593152466 abstract "Brown adipose tissue (BAT) recently emerged as a potential therapeutic target in the treatment of obesity and associated disorders due to its fat-burning capacity. The current gold standard in assessing BAT activity is [18F]FDG PET-CT scan, which has severe limitations including radiation exposure, being expensive, and being labor-intensive. Therefore, indirect markers are needed of human BAT activity and volume. We aimed to identify metabolites in serum that are associated with BAT volume and activity in men. We assessed 163 metabolites in fasted serum of a cohort of twenty-two healthy lean men (age 24.1 (21.7–26.6) years, BMI 22.1 (20.5–23.4) kg/m2) who subsequently underwent a cold-induced [18F]FDG PET-CT scan to assess BAT volume and activity. In addition, we included three replication cohorts consisting of in total thirty-seven healthy lean men that were similar with respect to age and BMI compared to the discovery cohort. After correction for multiple testing, fasting concentrations of lysophosphatidylcholine-acyl (LysoPC-acyl) C16:1, LysoPC-acyl C16:0 and phosphatidylcholine-diacyl C32:1 showed strong positive correlations with BAT volume (β= 116 (85–148) mL, R2 = 0.81, p = 4.6 × 10−7 ; β = 79 (93–119) mL, R2 = 0.57, p = 5.9 × 10−4 and β= 91 (40–141) mL, R2 = 0.52, p = 1.0 × 10−3, respectively) as well as with BAT activity (β= 0.20 (0.11–0.29) g/mL, R2 = 0.59, p = 1.9 × 10−4; β = 0.15 (0.06–0.23) g/mL, R2 = 0.47, p = 2.0 × 10−3 and β= 0.13 (0.01–0.25) g/mL, R2 = 0.28, p = 0.04, respectively). When tested in three independent replication cohorts (total n = 37), the association remained significant between LysoPC-acyl C16:0 and BAT activity in a pooled analysis (β= 0.15 (0.07–0.23) g/mL, R2 = 0.08, p = 4.2 × 10−4). LysoPC-acyl C16:0 is associated with BAT activity in men. Since BAT is regarded as a promising tool in the battle against obesity and related disorders, the identification of such a noninvasive marker is highly relevant." @default.
• W2593152466 created "2017-03-16" @default.
• W2593152466 creator A5021048991 @default.
• W2593152466 creator A5022816832 @default.
• W2593152466 creator A5024262405 @default.
• W2593152466 creator A5032537180 @default.
• W2593152466 creator A5035385427 @default.
• W2593152466 creator A5038716433 @default.
• W2593152466 creator A5042456739 @default.
• W2593152466 creator A5060123483 @default.
• W2593152466 creator A5061627231 @default.
• W2593152466 creator A5062964331 @default.
• W2593152466 creator A5080811781 @default.
• W2593152466 date "2017-03-03" @default.
• W2593152466 modified "2023-10-15" @default.
• W2593152466 title "LysoPC-acyl C16:0 is associated with brown adipose tissue activity in men" @default.
• W2593152466 cites W1127264686 @default.
• W2593152466 cites W1200115021 @default.
• W2593152466 cites W1965493220 @default.
• W2593152466 cites W2002632879 @default.
• W2593152466 cites W2005827500 @default.
• W2593152466 cites W2006141598 @default.
• W2593152466 cites W2006361510 @default.
• W2593152466 cites W2051993213 @default.
• W2593152466 cites W2053130274 @default.
• W2593152466 cites W2102921035 @default.
• W2593152466 cites W2103970225 @default.
• W2593152466 cites W2113504642 @default.
• W2593152466 cites W2115464767 @default.
• W2593152466 cites W2132358997 @default.
• W2593152466 cites W2137294760 @default.
• W2593152466 cites W2162023168 @default.
• W2593152466 cites W2167019376 @default.
• W2593152466 cites W2167372092 @default.
• W2593152466 cites W2230957038 @default.
• W2593152466 cites W2318465668 @default.
• W2593152466 cites W2475691803 @default.
• W2593152466 cites W2606498025 @default.
• W2593152466 doi "https://doi.org/10.1007/s11306-017-1185-z" @default.
• W2593152466 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5334436" @default.
• W2593152466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28316560" @default.
• W2593152466 hasPublicationYear "2017" @default.
• W2593152466 type Work @default.
• W2593152466 sameAs 2593152466 @default.
• W2593152466 citedByCount "21" @default.
• W2593152466 countsByYear W25931524662017 @default.
• W2593152466 countsByYear W25931524662018 @default.
• W2593152466 countsByYear W25931524662019 @default.
• W2593152466 countsByYear W25931524662020 @default.
• W2593152466 countsByYear W25931524662021 @default.
• W2593152466 countsByYear W25931524662022 @default.
• W2593152466 countsByYear W25931524662023 @default.
• W2593152466 crossrefType "journal-article" @default.
• W2593152466 hasAuthorship W2593152466A5021048991 @default.
• W2593152466 hasAuthorship W2593152466A5022816832 @default.
• W2593152466 hasAuthorship W2593152466A5024262405 @default.
• W2593152466 hasAuthorship W2593152466A5032537180 @default.
• W2593152466 hasAuthorship W2593152466A5035385427 @default.
• W2593152466 hasAuthorship W2593152466A5038716433 @default.
• W2593152466 hasAuthorship W2593152466A5042456739 @default.
• W2593152466 hasAuthorship W2593152466A5060123483 @default.
• W2593152466 hasAuthorship W2593152466A5061627231 @default.
• W2593152466 hasAuthorship W2593152466A5062964331 @default.
• W2593152466 hasAuthorship W2593152466A5080811781 @default.
• W2593152466 hasBestOaLocation W25931524661 @default.
• W2593152466 hasConcept C126322002 @default.
• W2593152466 hasConcept C134018914 @default.
• W2593152466 hasConcept C171089720 @default.
• W2593152466 hasConcept C185592680 @default.
• W2593152466 hasConcept C2776330855 @default.
• W2593152466 hasConcept C2778596009 @default.
• W2593152466 hasConcept C2778918659 @default.
• W2593152466 hasConcept C2780642333 @default.
• W2593152466 hasConcept C2989005 @default.
• W2593152466 hasConcept C41625074 @default.
• W2593152466 hasConcept C42407357 @default.
• W2593152466 hasConcept C55493867 @default.
• W2593152466 hasConcept C71924100 @default.
• W2593152466 hasConcept C72563966 @default.
• W2593152466 hasConcept C86803240 @default.
• W2593152466 hasConceptScore W2593152466C126322002 @default.
• W2593152466 hasConceptScore W2593152466C134018914 @default.
• W2593152466 hasConceptScore W2593152466C171089720 @default.
• W2593152466 hasConceptScore W2593152466C185592680 @default.
• W2593152466 hasConceptScore W2593152466C2776330855 @default.
• W2593152466 hasConceptScore W2593152466C2778596009 @default.
• W2593152466 hasConceptScore W2593152466C2778918659 @default.
• W2593152466 hasConceptScore W2593152466C2780642333 @default.
• W2593152466 hasConceptScore W2593152466C2989005 @default.
• W2593152466 hasConceptScore W2593152466C41625074 @default.
• W2593152466 hasConceptScore W2593152466C42407357 @default.
• W2593152466 hasConceptScore W2593152466C55493867 @default.
• W2593152466 hasConceptScore W2593152466C71924100 @default.
• W2593152466 hasConceptScore W2593152466C72563966 @default.
• W2593152466 hasConceptScore W2593152466C86803240 @default.
• W2593152466 hasFunder F4320321007 @default.
• W2593152466 hasFunder F4320321642 @default.
• W2593152466 hasFunder F4320321708 @default.
• W2593152466 hasFunder F4320334960 @default.
• W2593152466 hasIssue "5" @default.

• next